Growth Prospects of the EMEA(Europe, Middle East and Africa)Influenza Drugs and Vaccines Market 2017

EMEA(Europe, Middle East and Africa)Influenza Drugs and Vaccines Market Report 2017 is a new market research publication announced by Reportstack. In this report, the EMEA Influenza Drugs and Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. 

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Influenza Drugs and Vaccines for these regions, from 2012 to 2022 (forecast) 
Europe: Germany, France, UK, Russia, Italy and Benelux; 
Middle East: Saudi Arabia, Israel, UAE and Iran; 
Africa: South Africa, Nigeria, Egypt and Algeria. 

Complete report available @ EMEA(Europe, Middle East and Africa)Influenza Drugs and Vaccines Market Report 2017

EMEA Influenza Drugs and Vaccines market competition by top manufacturers/players, with Influenza Drugs and Vaccines sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including 

GlaxoSmithKline 
Sanofi Pasteur, Inc. 
CSL Limited 
Astrazeneca 
Protein Sciences Corporation 
Serum Institute Of India Pvt. Ltd. 
Emergent Biosolutions 
Emergent Biosolutions 
BioCryst Pharmaceuticals.Inc. 
Alvogen 
ABPI 
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into 
Zanamivir 
Oseltamivir Phosphate 
Peramivir 
Trivalent 
Quadrivalent 
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Influenza Drugs and Vaccines for each application, including 
Hospitals 
Research Laboratories 
Pharmacies 
Others

Snapshot of TOC with Companies Mentioned

6 EMEA Influenza Drugs and Vaccines Manufacturers/Players Profiles and Sales Data 
6.1 GlaxoSmithKline 
6.1.1 Company Basic Information, Manufacturing Base and Competitors 
6.1.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.1.2.1 Product A 
6.1.2.2 Product B 
6.1.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.1.4 Main Business/Business Overview 
6.2 Sanofi Pasteur, Inc. 
6.2.1 Company Basic Information, Manufacturing Base and Competitors 
6.2.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.2.2.1 Product A 
6.2.2.2 Product B 
6.2.3 Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.2.4 Main Business/Business Overview 
6.3 CSL Limited 
6.3.1 Company Basic Information, Manufacturing Base and Competitors 
6.3.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.3.2.1 Product A 
6.3.2.2 Product B 
6.3.3 CSL Limited Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.3.4 Main Business/Business Overview 
6.4 Astrazeneca 
6.4.1 Company Basic Information, Manufacturing Base and Competitors 
6.4.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.4.2.1 Product A 
6.4.2.2 Product B 
6.4.3 Astrazeneca Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.4.4 Main Business/Business Overview 
6.5 Protein Sciences Corporation 
6.5.1 Company Basic Information, Manufacturing Base and Competitors 
6.5.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.5.2.1 Product A 
6.5.2.2 Product B 
6.5.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.5.4 Main Business/Business Overview 
6.6 Serum Institute Of India Pvt. Ltd. 
6.6.1 Company Basic Information, Manufacturing Base and Competitors 
6.6.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.6.2.1 Product A 
6.6.2.2 Product B 
6.6.3 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.6.4 Main Business/Business Overview 
6.7 Emergent Biosolutions 
6.7.1 Company Basic Information, Manufacturing Base and Competitors 
6.7.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.7.2.1 Product A 
6.7.2.2 Product B 
6.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.7.4 Main Business/Business Overview 
6.8 Emergent Biosolutions 
6.8.1 Company Basic Information, Manufacturing Base and Competitors 
6.8.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.8.2.1 Product A 
6.8.2.2 Product B 
6.8.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.8.4 Main Business/Business Overview 
6.9 BioCryst Pharmaceuticals.Inc. 
6.9.1 Company Basic Information, Manufacturing Base and Competitors 
6.9.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.9.2.1 Product A 
6.9.2.2 Product B 
6.9.3 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.9.4 Main Business/Business Overview 
6.10 Alvogen 
6.10.1 Company Basic Information, Manufacturing Base and Competitors 
6.10.2 Influenza Drugs and Vaccines Product Type, Application and Specification 
6.10.2.1 Product A 
6.10.2.2 Product B 
6.10.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017) 
6.10.4 Main Business/Business Overview 
6.11 ABPI 

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###